Tumor Course

Tumor Course Faculty – 2025

Course Director

Rakesh K. Jain, Ph.D., Andrew Werk Cook Professor of Radiation Oncology (Tumor Biology), Harvard Medical School; Director, E.L. Steele Laboratories of Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA

Faculty

  • Lisa M. Coussens, Ph.D., Hildegard Lamfrom Chair in Basic Science; Professor and Chair, Cell and Developmental Biology; Associate Director for Basic Research, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA
  • Rakesh K. Jain, Ph.D., Andrew Werk Cook Professor of Tumor Biology, Harvard Medical School; Director, E.L. Steele Laboratories of Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA
  • Carl June, MD, Director of the Center for Cellular Immunotherapies, Penn Medicine, Philadelphia PA, USA
  • Jonathan Kipnis, Ph.D., BJC Investigator, Alan A. and Edith L. Wolff Distinguished Professor of Pathology and Immunology, Wash U Medicine, St. Louis MO, USA.
  • Hideho Okada, MD, Ph.D., Professor, Neurological Surgery, University of California San Francisco School of Medicine, San Francisco CA, USA
  • Arlene Sharpe, MD, PhD, Kolokotrones University Professor at Harvard University; Chair of the Department of Immunology at Harvard Medical School; Leader of the Cancer Immunology Program at Dana-Farber/Harvard Cancer Center; Vice Director of the Gene Lay Institute of Immunology and Inflammation at Brigham and Women’s Hospital, Massachusetts General Hospital, and Harvard Medical School, Boston MA, USA.
  • George Sledge, MD, Adjunct Clinical Professor, Medicine and Oncology, Stanford Medicine, Stanford CA, USA
  • Mario L. Suva, M.D., Ph.D., Associate Professor of Pathology, Massachusetts General Hospital and Harvard Medical School Associate Member at the Broad Institute of MIT and Harvard, Co-Director, Cancer Program, Harvard Stem Cell Institute, Boston, MA, USA.
  • Giorgio Trinchieri, MD, Head of Cancer Immunology Section, Laboratory of Integrative Cancer Immunology, NIH
  • David A. Tuveson, M.D., Ph.D., Professor and Director, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA
  • Eliezer Van Allen, MD, Chief, Division of Population Sciences, Chandra Nohria Family Chair for AI in Cancer Research, Physician, Associate Professor in Medicine, Harvard Medical School. 
  • Chi Van Dang, M.D., Ph.D., Scientific director, Ludwig Institute for Cancer Research; Bloomberg Distinguished Professor of Cancer Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
  • Matthew Vander Heiden, M.D., Ph.D., Associate Professor of Biology, Massachusetts Institute of Technology; Associate Director, Koch Institute for Integrative Cancer Research, Cambridge, MA, USA
  • Robert Wechsler-Reya, Ph.D., H. Houston Merritt Professor of Neurological Sciences, Scientific Director of Brain Tumor Research, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York City, NY, USA
  • Robert A. Weinberg, Ph.D., Daniel K. Ludwig Professor for Cancer Research at Massachusetts Institute of Technology, Director of the Ludwig Center of the MIT, and American Cancer Society Research Professor
  • Frank Winkler, MD, Ph.D., Full Professor for Neuro-Oncology, Heidelberg University; Managing Senior Physician, Dpt. of Neurology, University Clinic; and Group Leader, German Cancer Research Center, Heidelberg

Tumor Course Faculty (1986-present)